Clinical trialPhase 4Terminated
Nutrition and Pharmacological Algorithm for Oncology Patients Study
Assessing Quality of Life and the Feasibility of a Nutrition and Pharmacological Algorithm for Oncology Patients With Anorexia
- Outcome
- Stopped earlyThe trial was closed after 4 months due to slow to accrual. Only 1 participant was enrolled. (Enrollment)
- Phase
- Phase 4
- Status
- Terminated
- Study type
- Interventional
- Start
- 1 March 2021
- Expected end
- 5 April 2021
- Enrollment
- 1 participants
- Sites
- 1
- Primary outcomes
- Quality of Life Assessment
- Sponsor
- Other
- Results posted
- 2022-11-16
- Last update
- 16 November 2022
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
Loss of appetite is a common symptom of patients with cancer and can cause distress which impacts patients and caregivers. Patients diagnosed with head/neck, lung or pancreatic cancer will be recruited for this study to decrease the suffering and distress associated with eating during cancer treatment and improve the quality of life of patients by implementing an algorithm utilizing nutrition intervention and appetite stimulants.
Posted results (ClinicalTrials.gov registry) · primary outcome public domain (ClinicalTrials.gov)
Quality of Life Assessment [3 months].
Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)
Quality of Life/Appetite Assessment [3 months].